TME Pharma N.V. (0N6A) Stock Statistics & Valuation Metrics
Total Valuation
TME Pharma N.V. has a market cap or net worth of EUR 10.59M. The enterprise value is EUR 8.91M.
- Market Cap
- EUR 10.59M
- Enterprise Value
- EUR 8.91M
Share Statistics
TME Pharma N.V. has 96,688,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 96,688,980
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TME Pharma N.V.’s return on equity (ROE) is 2.08 and return on invested capital (ROIC) is -359.46%.
- Return on Equity (ROE)
- 2.08
- Return on Assets (ROA)
- -1.54
- Return on Invested Capital (ROIC)
- -359.46%
- Return on Capital Employed (ROCE)
- 1.84
- Revenue Per Employee
- 0
- Profits Per Employee
- -273.75K
- Employee Count
- 12
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of TME Pharma N.V. is -6.22. TME Pharma N.V.’s PEG ratio is -0.04.
- PE Ratio
- -6.22
- PS Ratio
- -394.03
- PB Ratio
- -4.05
- Price to FCF
- -7.69
- Price to Operating Cash Flow
- -7.63
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, TME Pharma N.V. had revenue of 0 and earned -3.29M in profits. Earnings per share was -0.03.
- Revenue
- 0
- Gross Profit
- -8,000
- Operating Income
- -2.91M
- Pretax Income
- -3.29M
- Net Income
- -3.29M
- EBITDA
- -2.90M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -1.38M and capital expenditures 0, giving a free cash flow of -1.38M billion.
- Operating Cash Flow
- -1.38M
- Free Cash Flow
- -1.38M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
TME Pharma N.V. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.00%
- Earnings Yield
- -16.02%
Stock Price Statistics
- Beta
- -0.11
- 52-Week Price Change
- 16.67%
- 50-Day Moving Average
- 0.11
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 45.33
- Average Volume (3m)
- 78.12K
Important Dates
TME Pharma N.V. upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 29, 2027
- Ex-Dividend Date
- ―
Financial Position
TME Pharma N.V. as a current ratio of 0.57, with Debt / Equity ratio of -151.23%
- Current Ratio
- 0.57
- Quick Ratio
- 0.57
- Debt to Market Cap
- 0.39
- Net Debt to EBITDA
- -0.13
- Interest Coverage Ratio
- -2.67
Taxes
In the past 12 months, TME Pharma N.V. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
TME Pharma N.V. EV to EBITDA ratio is -10.05, with an EV/FCF ratio of -9.04.
- EV to Sales
- -463.07
- EV to EBITDA
- -10.05
- EV to Free Cash Flow
- -9.04
- EV to Operating Cash Flow
- -9.04
Balance Sheet
TME Pharma N.V. has EUR 1.03M in cash and marketable securities with EUR 2.89M in debt, giving a net cash position of -EUR 1.86M billion.
- Cash & Marketable Securities
- EUR 1.03M
- Total Debt
- EUR 2.89M
- Net Cash
- -EUR 1.86M
- Net Cash Per Share
- -EUR 0.02
- Tangible Book Value Per Share
- -EUR 0.03
Margins
Gross margin is 37.04%, with operating margin of 4351.85%, and net profit margin of 6259.26%.
- Gross Margin
- 37.04%
- Operating Margin
- 4351.85%
- Pretax Margin
- 6259.26%
- Net Profit Margin
- 6259.26%
- EBITDA Margin
- 4607.41%
- EBIT Margin
- 4618.52%
